New Bicaplus Tablet 10/40/12.5 mg

Adult dose

This medication is taken once daily at 1 tablet, with or without food. It is recommended to take it at the same time every day (e.g., in the morning) if possible. The recommended dosage is as follows: - 5/20/12.5 mg: Administered to patients whose blood pressure is not adequately controlled with the combination therapy of Amlodipine/Olmesartan Medoxomil 5/20 mg. - 5/40/12.5 mg: Administered to patients whose blood pressure is not adequately controlled with the combination therapy of Amlodipine/Olmesartan Medoxomil 5/40 mg.

Child dose

The safety and efficacy of this medication have not been established in patients under 18 years of age, and its use is not recommended.

This medication should not be used during the second and third trimesters of pregnancy, as taking this drug during pregnancy can cause severe harm or even death to the fetus or newborn. Patients with allergies or hypersensitivity to the components of this drug or similar classes of drugs should not take it. Additionally, women who are pregnant or breastfeeding, patients with severe hypotension, and patients with heart or kidney problems may be at risk if they use this medication. Patients with low blood volume or reduced sodium levels may experience hypotension when initially taking this drug, so caution is required. Such patients should closely monitor their condition before starting treatment and may need fluid therapy if necessary. Patients with impaired kidney function, weakened liver function, specific heart diseases, or systemic lupus erythematosus should be especially cautious when using this medication. As this drug lowers blood pressure, dizziness or lightheadedness may occur. Care should be taken when driving or operating machinery. During the course of taking this medication, electrolyte levels in the blood, especially potassium and sodium levels, should be regularly checked. Electrolyte imbalances may lead to symptoms such as muscle weakness, cramps, and heart irregularities, necessitating caution. This drug may interact with other medications, so it is important to inform a doctor or pharmacist, especially if taking lithium, nonsteroidal anti-inflammatory drugs (NSAIDs), or other antihypertensives. Women who are breastfeeding are advised to avoid using this drug and may need to discontinue breastfeeding if unavoidable. The safety and efficacy of this medication have not been established in children under 18 years of age, and its use is not recommended. For the elderly, dosage adjustments should be made carefully, taking into account liver or kidney function decline. In case of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur, requiring immediate medical attention. This medication should be stored in a tightly sealed container to protect it from light and moisture, and out of the reach of children.

Serious side effects

Hives, severe swelling (edema), severe allergic reactions, severe rash with high fever, blisters, skin peeling, pain in the mucous membranes of the mouth/eyes, severe skin adverse reactions, difficulty breathing or shortness of breath, asthma attacks, respiratory issues accompanied by cough and fever, jaundice, liver abnormalities, sudden and extremely severe headaches, lightning headaches, seizures, confusion, visual disturbances, paralysis, severe neurological symptoms, significantly reduced urine output.

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• nasopharyngitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. Additionally, it is important to store the medication at room temperature between 1 and 30 degrees Celsius to maintain its effectiveness.

Appearance

Gray-red, round film-coated tablet

Package unit

30 tablets/PTP [10 tablets/Alu-Alu×3]